IS7341A - Trísýklísk 2-pýrimídón efnasambönd, gagnleg sem HIV-víxlritatálmar - Google Patents

Trísýklísk 2-pýrimídón efnasambönd, gagnleg sem HIV-víxlritatálmar

Info

Publication number
IS7341A
IS7341A IS7341A IS7341A IS7341A IS 7341 A IS7341 A IS 7341A IS 7341 A IS7341 A IS 7341A IS 7341 A IS7341 A IS 7341A IS 7341 A IS7341 A IS 7341A
Authority
IS
Iceland
Prior art keywords
tricyclic
inhibitors
compounds useful
pyrimidone compounds
hiv cross
Prior art date
Application number
IS7341A
Other languages
English (en)
Inventor
M. Tarby Christine
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of IS7341A publication Critical patent/IS7341A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS7341A 2002-01-18 2004-06-30 Trísýklísk 2-pýrimídón efnasambönd, gagnleg sem HIV-víxlritatálmar IS7341A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34964102P 2002-01-18 2002-01-18
PCT/US2003/001604 WO2003062238A1 (en) 2002-01-18 2003-01-16 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
IS7341A true IS7341A (is) 2004-06-30

Family

ID=27613304

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7341A IS7341A (is) 2002-01-18 2004-06-30 Trísýklísk 2-pýrimídón efnasambönd, gagnleg sem HIV-víxlritatálmar

Country Status (21)

Country Link
US (2) US6844340B2 (is)
EP (1) EP1474424A4 (is)
JP (1) JP2005519910A (is)
KR (1) KR20040077735A (is)
CN (1) CN1642954A (is)
AR (1) AR038164A1 (is)
BR (1) BR0306927A (is)
CA (1) CA2473420A1 (is)
CO (1) CO5590961A2 (is)
HR (1) HRP20040643A2 (is)
IL (1) IL162743A0 (is)
IS (1) IS7341A (is)
MX (1) MXPA04006948A (is)
NO (1) NO20043424L (is)
PE (1) PE20030987A1 (is)
PL (1) PL371418A1 (is)
RU (1) RU2004125151A (is)
TW (1) TW200306192A (is)
WO (1) WO2003062238A1 (is)
YU (1) YU62504A (is)
ZA (1) ZA200405139B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2002000136A (es) 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis
US7094909B2 (en) 2001-06-11 2006-08-22 Agouron Pharmaceuticals, Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
US7169932B2 (en) 2001-06-11 2007-01-30 Pfizer Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
TW200306192A (en) * 2002-01-18 2003-11-16 Bristol Myers Squibb Co Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
CN102151270A (zh) 2003-02-07 2011-08-17 詹森药业有限公司 预防hiv感染的嘧啶衍生物
WO2008004100A2 (en) 2006-07-05 2008-01-10 Pfizer Products Inc. Therapeutic compounds
US20080119552A1 (en) * 2006-11-17 2008-05-22 Novus International Inc. Matrix-embedded compositions having organic acids and fatty acids
US7964608B2 (en) 2008-01-25 2011-06-21 High Point Pharmaceuticals, Llc Tricyclic compounds as modulators of TNF-α synthesis
AU2010334958B2 (en) 2009-12-23 2015-02-05 Katholieke Universiteit Leuven Novel antiviral compounds
CA2817896A1 (en) 2010-11-15 2012-05-24 Viiv Healthcare Uk Limited Inhibitors of hiv replication
AU2011331301A1 (en) 2010-11-15 2013-05-23 Katholieke Universiteit Leuven Antiviral condensed heterocyclic compounds
CN103130787B (zh) * 2011-11-24 2015-06-10 南开大学 嘧啶酮酰胺类化合物及其制备方法、抗hiv活性和抗tmv活性
GB201509663D0 (en) * 2015-06-03 2015-07-15 Johnson Matthey Plc Benzo(h)quinoline ligands and complexes thereof
AU2021315488A1 (en) 2020-07-28 2023-03-23 Vtv Therapeutics Llc Crystalline form of hydrochloride salt of quinoline derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593337B1 (en) * 1999-10-19 2003-07-15 Bristol-Myers Squibb Pharma Company Tricyclic compounds useful as HIV reverse transcriptase inhibitors
US6596729B2 (en) 2000-07-20 2003-07-22 Bristol-Myers Squibb Company Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
TW200306192A (en) * 2002-01-18 2003-11-16 Bristol Myers Squibb Co Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors

Also Published As

Publication number Publication date
YU62504A (sh) 2006-08-17
WO2003062238A1 (en) 2003-07-31
HRP20040643A2 (en) 2005-04-30
EP1474424A1 (en) 2004-11-10
EP1474424A4 (en) 2005-12-28
US7186830B2 (en) 2007-03-06
MXPA04006948A (es) 2004-12-06
US20030162800A1 (en) 2003-08-28
CO5590961A2 (es) 2005-12-30
JP2005519910A (ja) 2005-07-07
RU2004125151A (ru) 2006-02-20
PL371418A1 (en) 2005-06-13
KR20040077735A (ko) 2004-09-06
IL162743A0 (en) 2005-11-20
ZA200405139B (en) 2006-02-22
US20040266778A1 (en) 2004-12-30
US6844340B2 (en) 2005-01-18
AR038164A1 (es) 2004-12-29
CA2473420A1 (en) 2003-07-31
NO20043424L (no) 2004-08-18
PE20030987A1 (es) 2003-11-15
CN1642954A (zh) 2005-07-20
TW200306192A (en) 2003-11-16
BR0306927A (pt) 2004-11-09

Similar Documents

Publication Publication Date Title
EG24775A (en) Acetamide compounds as fungicides.
EG25148A (en) Process for the manufacture of 1,2-dichloroethane.
EG25281A (en) Process for the manufacture of 1,2-dichloroethane.
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
DK1797099T3 (da) Piperidinylamino-thieno[2,3-D]pyrimidinforbindelser
IS2956B (is) 3-sýklóalkýlamínópýrrólidínafleiður sem stillar á flakkboðaviðtaka
EG25273A (en) Substituted dihydroquinazolines.
IS2577B (is) Trópan afleiður sem CCR5 stillar
IS7341A (is) Trísýklísk 2-pýrimídón efnasambönd, gagnleg sem HIV-víxlritatálmar
DE60305332D1 (de) IMIDAZOi1,2-AöPYRIDINE
IL178166A0 (en) 1,3,4-oxadiazol-2-ones as ppar delta
IS7795A (is) Pyrrólafleiður sem efnasambönd gegn sveppagerlum
MXPA03009482A (es) Compuestos triciclicos utiles como inhibidores de la transcriptasa inversa del virus de inmunodeficiencia humana (vih).
SI1951697T1 (sl) Substituirani 5-fenil-3,6-dihidro-2-okso-6h-(1,3,4)tiadiazini
NL1030010A1 (nl) 4-Amino-gesubstitueerde-2-gesubstitueerde-1,2,3,4- tetrahydrochinolineverbindingen.
AP2006003588A0 (en) Compounds artemisinin.
ZA200306629B (en) Polymer modified gypsum composition.
GB0425572D0 (en) 1,7-Naphthyridines
EP1723145A4 (en) SUBSTITUTED 5,12-DIAZENZOANTHRACENANALOGA
GB0322402D0 (en) HIV pharmaccines
HK1069825A (en) Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
ITBO20030038A1 (it) Conglomerato, particolarmente per la realizzazione
ES1052333Y (es) Cajon premarco.
NL1024812A1 (nl) Lampenkap.
DE50301007D1 (de) Sportschuh, insbesondere skischuh